The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Morris Milton Mayo | Director | Sell(S) | 15K | $1.41 | $21K |
| Aug 20, 2026 | Kovelman Harry | Chief Medical Officer | Sell(S) | 18K | $1.73 | $30K |
| Aug 7, 2026 | Gudonis Paul R | Chief Executive Officer, Director | Grant(A) | 147K | — | $0 |
| Aug 7, 2026 | Henry David A | Chief Financial Officer | Grant(A) | 69K | — | $0 |
| Aug 7, 2026 | Henry David A | Chief Financial Officer | Tax withholding(F) | 25K | $1.42 | $36K |
| Aug 7, 2026 | Kovelman Harry | Chief Medical Officer | Grant(A) | 55K | — | $0 |
| Aug 7, 2026 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 22K | $1.42 | $32K |
| Aug 7, 2026 | Mitchell Micah | Chief Commercial Officer | Grant(A) | 58K | — | $0 |
| Aug 7, 2026 | Mitchell Micah | Chief Commercial Officer | Tax withholding(F) | 22K | $1.42 | $31K |
| Jul 13, 2026 | Henry David A | Chief Financial Officer | Tax withholding(F) | 5K | $1.09 | $6K |
| Jul 10, 2026 | Henry David A | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Jul 10, 2026 | Gudonis Paul R | Chief Executive Officer, Director | Grant(A) | 10K | — | $0 |
| Jun 25, 2026 | Manko Joseph M. Jr. | Director | Grant(A) | 79K | — | $0 |
| Jun 25, 2026 | Crowley Thomas Aloysius Jr. | Director | Grant(A) | 79K | — | $0 |
| Jun 25, 2026 | Kirk Thomas F | Director | Grant(A) | 79K | — | $0 |
| Jun 25, 2026 | Getz Heather C | Director | Grant(A) | 79K | — | $0 |
| Jun 25, 2026 | Febbo William J | Director | Grant(A) | 79K | — | $0 |
| Jun 25, 2026 | Morris Milton Mayo | Director | Grant(A) | 79K | — | $0 |
| Jun 12, 2026 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 10K | $1.20 | $13K |
| Jun 12, 2026 | Henry David A | Chief Financial Officer | Tax withholding(F) | 11K | — | $0 |
| Jun 12, 2026 | Mitchell Micah | Chief Commercial Officer | Tax withholding(F) | 9K | $1.20 | $11K |
| Jun 8, 2026 | Mitchell Micah | Chief Commercial Officer | Tax withholding(F) | 7K | $1.33 | $9K |
| Jun 8, 2026 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 8K | $1.33 | $10K |
| Jun 8, 2026 | Henry David A | Chief Financial Officer | Tax withholding(F) | 10K | — | $0 |
| Jun 5, 2026 | Kirk Thomas F | Director | Buy(P) | 40K | $1.27 | $51K |
| May 28, 2026 | Kovelman Harry | Chief Medical Officer | Sell(S) | 12K | $1.02 | $12K |
| May 28, 2026 | Kirk Thomas F | Director | Buy(P) | 25K | $0.99 | $25K |
| May 27, 2026 | Kovelman Harry | Chief Medical Officer | Sell(S) | 20K | $1.00 | $21K |
| May 18, 2026 | Kirk Thomas F | Director | Buy(P) | 43K | $0.91 | $39K |
| May 15, 2026 | Manko Joseph M. Jr. | Director | Buy(P) | 30K | $0.89 | $27K |
| May 15, 2026 | Kirk Thomas F | Director | Buy(P) | 32K | $0.91 | $29K |
| May 14, 2026 | Mitchell Micah | Chief Commercial Officer | Sell(S) | 90K | $0.86 | $78K |
| May 14, 2026 | Manko Joseph M. Jr. | Director | Buy(P) | 171K | $0.86 | $147K |
| Apr 14, 2026 | Febbo William J | Director | Grant(A) | 45K | — | $0 |
| Apr 13, 2026 | Henry David A | Chief Financial Officer | Tax withholding(F) | 4K | $0.71 | $3K |
| Apr 10, 2026 | Henry David A | Chief Financial Officer | Grant(A) | 13K | — | $0 |
| Apr 10, 2026 | Gudonis Paul R | Chief Executive Officer, Director | Grant(A) | 17K | — | $0 |
| Mar 16, 2026 | Getz Heather C | Director | Buy(P) | 20K | $0.70 | $14K |
| Mar 13, 2026 | Kirk Thomas F | Director | Buy(P) | 72K | $0.71 | $51K |
| Mar 12, 2026 | Getz Heather C | Director | Buy(P) | 70K | $0.73 | $51K |
| Jan 12, 2026 | Henry David A | Chief Financial Officer | Grant(A) | 9K | — | $0 |
| Jan 12, 2026 | Gudonis Paul R | Chief Executive Officer, Director | Grant(A) | 12K | — | $0 |
| Nov 21, 2025 | Kirk Thomas F | Director | Buy(P) | 3K | $0.72 | $2K |
| Nov 20, 2025 | Kirk Thomas F | Director | Buy(P) | 5K | $0.72 | $4K |
| Nov 19, 2025 | Crowley Thomas Aloysius Jr. | Director | Buy(P) | 385 | $0.77 | $296 |
| Nov 18, 2025 | Crowley Thomas Aloysius Jr. | Director | Buy(P) | 4K | $0.73 | $3K |
| Sep 9, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Gift(G) | 10K | — | $0 |
| Aug 25, 2025 | Kirk Thomas F | Director | Buy(P) | 50K | $1.15 | $58K |
| Aug 18, 2025 | Kirk Thomas F | Director | Buy(P) | 50K | $1.10 | $55K |
| Aug 15, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Buy(P) | 50K | $0.95 | $48K |
| Jun 30, 2025 | Henry David A | Chief Financial Officer | Tax withholding(F) | 24K | $2.19 | $52K |
| Jun 30, 2025 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 13K | $2.19 | $29K |
| Jun 11, 2025 | Getz Heather C | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2025 | Morris Milton Mayo | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2025 | Crowley Thomas Aloysius Jr. | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2025 | Kirk Thomas F | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Grant(A) | 157K | — | $0 |
| Jun 11, 2025 | Henry David A | Chief Financial Officer | Grant(A) | 76K | — | $0 |
| Jun 11, 2025 | Mitchell Micah | Chief Commercial Officer | Grant(A) | 59K | — | $0 |
| Jun 11, 2025 | Kovelman Harry | Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Jun 6, 2025 | Henry David A | Chief Financial Officer | Tax withholding(F) | 8K | $2.97 | $25K |
| Jun 6, 2025 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 6K | $2.97 | $17K |
| May 15, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Buy(P) | 30K | $3.22 | $97K |
| May 15, 2025 | Kirk Thomas F | Director | Buy(P) | 37K | $3.25 | $120K |
| May 14, 2025 | Kirk Thomas F | Director | Buy(P) | 2K | $3.25 | $6K |
| May 14, 2025 | Mitchell Micah | Chief Commercial Officer | Sell(S) | 90K | $0.86 | $78K |
| May 12, 2025 | Kirk Thomas F | Director | Buy(P) | 50K | $3.35 | $168K |
| Mar 14, 2025 | Mitchell Micah | Chief Commercial Officer | Sell(S) | 48K | $5.16 | $248K |
| Mar 13, 2025 | Henry David A | Chief Financial Officer | Tax withholding(F) | 2K | $5.22 | $11K |
| Mar 13, 2025 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 1K | $5.22 | $8K |
| Mar 13, 2025 | Mitchell Micah | Chief Commercial Officer | Tax withholding(F) | 1K | $5.22 | $7K |
| Mar 13, 2025 | Kirk Thomas F | Director | Buy(P) | 7K | $5.00 | $37K |
| Mar 12, 2025 | Kovelman Harry | Chief Medical Officer | Sell(S) | 30K | $5.50 | $165K |
| Mar 11, 2025 | Henry David A | Chief Financial Officer | Grant(A) | 4K | — | $0 |
| Mar 11, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Grant(A) | 7K | — | $0 |
| Mar 11, 2025 | Kovelman Harry | Chief Medical Officer | Grant(A) | 4K | — | $0 |
| Mar 11, 2025 | Mitchell Micah | Chief Commercial Officer | Grant(A) | 4K | — | $0 |
| Feb 13, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Option exercise(M) | 694 | $0.05 | $35 |
| Feb 13, 2025 | Gudonis Paul R | Chief Executive Officer, Director | Option exercise(M) | 694 | — | $0 |
| Nov 4, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 121 | $3.70 | $448 |
| Oct 3, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 121 | $3.86 | $467 |
| Sep 5, 2024 | Kovelman Harry | Chief Medical Officer | Sell(S) | 7K | $3.76 | $25K |
| Sep 4, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 139 | $3.89 | $541 |
| Sep 3, 2024 | Kovelman Harry | Chief Medical Officer | Sell(S) | 2K | $4.01 | $8K |
| Aug 5, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 128 | $3.96 | $507 |
| Jul 3, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 121 | $2.85 | $345 |
| Jul 1, 2024 | Henry David A | Chief Financial Officer | Tax withholding(F) | 25K | $3.02 | $77K |
| Jul 1, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 13K | $3.02 | $39K |
| Jul 1, 2024 | Mitchell Micah | Chief Commercial Officer | Tax withholding(F) | 16K | $3.02 | $47K |
| Jun 10, 2024 | Kovelman Harry | Chief Medical Officer | Tax withholding(F) | 5K | $3.38 | $18K |
| Jun 10, 2024 | Mitchell Micah | Chief Commercial Officer | Tax withholding(F) | 7K | $3.38 | $23K |
| Jun 10, 2024 | Henry David A | Chief Financial Officer | Tax withholding(F) | 11K | $3.38 | $36K |
| Jun 9, 2024 | Gudonis Paul R | Chief Executive Officer, Director | Option exercise(M) | 6K | — | $0 |
| Jun 9, 2024 | Gudonis Paul R | Chief Executive Officer, Director | Option exercise(M) | 6K | — | $0 |
| Jun 9, 2024 | Kovelman Harry | Chief Medical Officer | Option exercise(M) | 1K | — | $0 |
| Jun 9, 2024 | Kovelman Harry | Chief Medical Officer | Option exercise(M) | 1K | — | $0 |
| Jun 9, 2024 | Henry David A | Chief Financial Officer | Option exercise(M) | 3K | — | $0 |
| Jun 9, 2024 | Henry David A | Chief Financial Officer | Option exercise(M) | 3K | — | $0 |
| Jun 9, 2024 | Mitchell Micah | Chief Commercial Officer | Option exercise(M) | 2K | — | $0 |
| Jun 9, 2024 | Mitchell Micah | Chief Commercial Officer | Option exercise(M) | 2K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Myomo, Inc., SEC CIK 0001369290. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under MYO and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for MYO